Alzheon
Alzheon is a clinical-stage biopharmaceutical company that develops therapies for Alzheimer’s disease and other neurodegenerative disorders.
$100M Series B+ ·
Led by Alerce Medical Technology Partners · Source: startupintros.com
Total raised: $110M across 2 sourced rounds
All 2 rounds ↓Signals
About Alzheon
It creates oral small-molecule candidates designed to target amyloid aggregation. Alzheon's customers are patients suffering from these diseases.
Alzheon | 655 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $100M | AAlerce Medical Technology Partners | startupintros.com | |
| Series A | $10M | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
MT
Martin Tolar founderAP
Aidan Power Chief Development OfficerDL
Dina Lynch Vice President of Market AccessJH
John Hey Chief Scientific OfficerKM
Ken Mace Chief Financial OfficerNG
Nate Greene Vice President of Brand MarketingSA
Susan Abushakra Chief Medical OfficerYK
Yasemin Khakian Chief of Staff
Investors
- AAlerce Medical Technology Partnerslead investor
AAlly Bridge Grouplead investor
NNational Institute on Aging
SScott H. Cohen
Companies like Alzheon
SStorm Therapeutics$56M Series B+ · Apr 2026
CCellCentric$220M Series B+ · May 2026
MMwyngil TherapeuticsSeed · Jun 2026
NNoema PharmaSeries B+ · Nov 2025
CClaris Bio$118M Series B+ · Jul 2026
RRgenta TherapeuticsSeries B+ · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/alzheon (get a free API key).